Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Infections”

111 trials

Showing 20 of 111 results

Not applicableStudy completedNCT02911415
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

Who this might be right for
Ebola Hemorrhagic Fever
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Testing effectiveness (Phase 2)Study completedNCT03929757
What this trial is testing

2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 108
Not applicableStudy completedNCT02658331
What this trial is testing

Evaluation of the FilmArray BioThreat-E Test

Who this might be right for
Ebola Virus Disease
BioMérieux 156
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Early research (Phase 1)Study completedNCT03475056
What this trial is testing

CAd3-Marburg Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Looking for participantsNCT07565090
What this trial is testing

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Who this might be right for
Sudan Virus Disease
International AIDS Vaccine Initiative 112
Not applicableStudy completedNCT02911428
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac

Who this might be right for
Hemorrhagic Fever, Ebola
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Early research (Phase 1)Study completedNCT02354404
What this trial is testing

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT02431923
What this trial is testing

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,043
Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Testing effectiveness (Phase 2)Study completedNCT02818582
What this trial is testing

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

Who this might be right for
Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 38
Large-scale testing (Phase 3)Looking for participantsNCT06126822
What this trial is testing

Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC

Who this might be right for
Ebola Virus Disease
Institute of Tropical Medicine, Belgium 624
Large-scale testing (Phase 3)WithdrawnNCT02307591
What this trial is testing

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Who this might be right for
Ebola Virus Disease
Emergency NGO Onlus
Not applicableUnknownNCT02333578
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment

Who this might be right for
Ebola Virus Disease
Clinical Research Management, Inc. 70
Testing effectiveness (Phase 2)UnknownNCT04822376
What this trial is testing

Prophylaxis Vaccine Antibodies Ebola

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 250
Large-scale testing (Phase 3)Study completedNCT04228783
What this trial is testing

2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

Who this might be right for
Ebola
Janssen Vaccines & Prevention B.V. 974
Testing effectiveness (Phase 2)Study completedNCT02662855
What this trial is testing

Efficacy of Favipiravir Against Severe Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Beijing Institute of Pharmacology and Toxicology 77
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation